Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) announced its earnings results on Thursday. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01, FiscalAI reports. The company had revenue of $2.00 million for the quarter, compared to analyst estimates of $1.24 million. Aclaris Therapeutics had […]

Airbnb (NASDAQ:ABNB – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.31 by ($0.05), FiscalAI reports. The firm had revenue of $2.68 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Airbnb had a return on […]

Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.03), FiscalAI reports. Here are the key takeaways from Amylyx Pharmaceuticals’ conference call: Avexitide LUCIDITY randomized and dosed its last participant in late […]